Digestive and Liver Disease
Volume 43, Issue 1 , Pages 60-65 , January 2011

Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the “Cholangiocarcinoma” committee of the Italian Association for the Study of Liver disease

  • Domenico Alvaro

      Affiliations

    • Department of Clinical Medicine, Division of Gastroenterology, Polo Pontino, Sapienza University of Rome, Rome, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 06 49972023; fax: +39 06 4453319.
    • ,
  • Maria Consiglia Bragazzi

      Affiliations

    • Department of Clinical Medicine, Division of Gastroenterology, Polo Pontino, Sapienza University of Rome, Rome, Italy
    • ,
  • Antonio Benedetti

      Affiliations

    • Department of Gastroenterology, Università Politecnica delle Marche, Ancona, Italy
    • ,
  • Luca Fabris

      Affiliations

    • Department of Surgical and Gastroenterological Sciences, University of Padova, Padova, Italy
    • ,
  • Giammarco Fava

      Affiliations

    • Department of Gastroenterology, Università Politecnica delle Marche, Ancona, Italy
    • ,
  • Pietro Invernizzi

      Affiliations

    • Division of Internal Medicine and Hepatobiliary Immunopathology Unit, IRCCS Istituto Clinico Humanitas, Rozzano, Italy
    • ,
  • Marco Marzioni

      Affiliations

    • Department of Gastroenterology, Università Politecnica delle Marche, Ancona, Italy
    • ,
  • Gennaro Nuzzo

      Affiliations

    • Catholic University of Sacred Heart, Agostino Gemelli Medical School, Rome, Italy
    • ,
  • Mario Strazzabosco

      Affiliations

    • Universita’ di Milano Bicocca, Italy
    • ,
  • Tommaso Stroffolini

      Affiliations

    • Department of Infectious and Tropical Diseases, Sapienza University of Rome, Rome, Italy
    • ,
  • from the AISF “Cholangiocarcinoma” committee

      Affiliations

    • Composition of the AISF (Italian Association for the Study of Liver disease) “Cholangiocarcinoma” committee: Alvaro Domenico (Coordinator), Benedetti Antonio, Bragazzi MariaConsiglia, Capocaccia Riccardo, Crocetti Emanuele, Fabris Luca, Fava Giammarco; Ferretti Stefano, Floreani AnnaRosa, Grazi Gianluca, Invernizzi Pietro, Laghi Andrea, Mancino MariaGrazia, Marzioni Marco, Mutignani Massimiliano, Nuzzo Gennaro, Paolantonio Pasquale, Sonzogni Aurelio, Strazzabosco Mario, Stroffolini Tommaso.

Received 10 March 2010 ,Accepted 3 May 2010.

References 

  1. Blechacz B, Gores GJ. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology. 2008;48:308–321
  2. Lazaridis KN, Gores GJ. Cholangiocarcinoma. Gastroenterology. 2005;128:1655–1667
  3. Khan SA, Miras A, Pelling M, et al. Cholangiocarcinoma and its management. Gut. 2007;56:1755–1756
  4. Patel T, Singh P. Cholangiocarcinoma: emerging approaches to a challenging cancer. Curr Opin Gastroenterol. 2007;23:317–323
  5. Yachimski P, Pratt DS. Cholangiocarcinoma: natural history, treatment, and strategies for surveillance in high-risk patients. J Clin Gastroenterol. 2008;42:178–190
  6. Alvaro D, Mancino MG. New insights on the molecular and cell biology of human cholangiopathies. Mol Aspects Med. 2008;29:50–57
  7. Alvaro D, Mancino MG, Glaser S, et al. Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology. 2007;132:415–431
  8. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001;33:1353–1357
  9. McGlynn KA, Tarone RE, El-Serag HB. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev. 2006;15:1198–1203
  10. Welzel TM, McGlynn KA, Hsing AW, et al. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst. 2006;98:873–875
  11. Shaib YH, Davila JA, McGlynn K, et al. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?. J Hepatol. 2004;40:472–477
  12. Wood R, Brewster DH, Fraser LA, et al. Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in Scotland. Eur J Cancer. 2003;39:2087–2092
  13. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer. 2002;2:10
  14. West J, Wood H, Logan RF, et al. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001. Br J Cancer. 2006;94:1751–1758
  15. Alvaro D, Crocetti E, Ferretti S, et al. Descriptive epidemiology of cholangiocarcinoma in Italy. Digest Liver Dis; in press.
  16. Alvaro D. Serum and bile biomarkers for cholangiocarcinoma. Curr Opin Gastroenterol. 2009;25:279–284
  17. Alvaro D, Macarri G, Mancino MG, et al. Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis. Ann Intern Med. 2007;147:451–459
  18. Alexopoulou A, Soultati A, Dourakis SP, et al. Cholangiocarcinoma: a 7-year experience at a single center in Greece. World J Gastroenterol. 2008;14:6213–6217
  19. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224:463–473
  20. Kaczynski J, Hansson G, Wallerstedt S. Incidence, etiologic aspects and clinicopathologic features in intrahepatic cholangiocellular carcinoma—a study of 51 cases from a low-endemicity area. Acta Oncol. 1998;37:77–83
  21. Boberg KM, Bergquist A, Mitchell S, et al. Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol. 2002;37:1205–1211
  22. El-Serag HB, Engels EA, Landgren O, et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans. Hepatology. 2009;49:116–123
  23. Lee TY, Lee SS, Jung SW, et al. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case–control study. Am J Gastroenterol. 2008;103:1716–1720
  24. Donato F, Gelatti U, Tagger A, et al. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case–control study in Italy. Cancer Causes Control. 2001;12:959–964
  25. Kobayashi M, Ikeda K, Saitoh S, et al. Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis. Cancer. 2000;88:2471–2477
  26. Gores GJ. Cholangiocarcinoma: current concepts and insights. Hepatology. 2003;37:961–969
  27. Khan SA, Davidson BR, Goldin R, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut. 2002;51(Suppl. 6):VI1–VI9
  28. Corvera CU, Blumgart LH, Akhurst T, et al. 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg. 2008;206:57–65

PII: S1590-8658(10)00166-0

doi: 10.1016/j.dld.2010.05.002

Digestive and Liver Disease
Volume 43, Issue 1 , Pages 60-65 , January 2011

Article Tools